GB9318144D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9318144D0
GB9318144D0 GB939318144A GB9318144A GB9318144D0 GB 9318144 D0 GB9318144 D0 GB 9318144D0 GB 939318144 A GB939318144 A GB 939318144A GB 9318144 A GB9318144 A GB 9318144A GB 9318144 D0 GB9318144 D0 GB 9318144D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939318144A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB939318144A priority Critical patent/GB9318144D0/en
Publication of GB9318144D0 publication Critical patent/GB9318144D0/en
Priority to PCT/EP1994/002894 priority patent/WO1995006649A1/en
Priority to AU76925/94A priority patent/AU7692594A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/29—Micromonospora

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB939318144A 1993-09-01 1993-09-01 Organic compounds Pending GB9318144D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB939318144A GB9318144D0 (en) 1993-09-01 1993-09-01 Organic compounds
PCT/EP1994/002894 WO1995006649A1 (en) 1993-09-01 1994-08-31 Macrolides as antagonists of macrophilin binding immunosuppressants
AU76925/94A AU7692594A (en) 1993-09-01 1994-08-31 Macrolides as antagonists of macrophilin binding immunosuppressants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939318144A GB9318144D0 (en) 1993-09-01 1993-09-01 Organic compounds

Publications (1)

Publication Number Publication Date
GB9318144D0 true GB9318144D0 (en) 1993-10-20

Family

ID=10741346

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939318144A Pending GB9318144D0 (en) 1993-09-01 1993-09-01 Organic compounds

Country Status (3)

Country Link
AU (1) AU7692594A (en)
GB (1) GB9318144D0 (en)
WO (1) WO1995006649A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124453A (en) * 1995-07-04 2000-09-26 Novartis Ag Macrolides
AR006514A1 (en) * 1995-07-04 1999-09-08 Sandoz Ag A MACROLID, ITS USES, A PROCESS TO PRODUCE IT, A BIOLOGICALLY PURE ISOLATE CAPABLE OF PRODUCING IT, AND A PHARMACEUTICAL COMPOSITION THAT IT INCLUDES
US5912224A (en) * 1996-02-22 1999-06-15 The General Hospital Corporation Methods and compositions for enhancing cellular response to TGF-β ligands
BR0209474A (en) * 2001-05-09 2006-02-07 Novartis Ag Methods for Selective Immunomodulation
US7186518B2 (en) * 2003-11-21 2007-03-06 Dade Behring Inc. Method and composition useful for determining FK 506
JP2009529049A (en) 2006-03-07 2009-08-13 ワイス Meridamycin analogs for the treatment of neurological disorders
GB201122305D0 (en) 2011-12-23 2012-02-01 Biotica Tech Ltd Novel compound
EP3576736A4 (en) 2017-02-10 2020-08-26 Torcept Therapeutics Inc. Rapamycin analog

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4843008A (en) * 1984-12-24 1989-06-27 Yamanouchi Pharmaceutical Co., Ltd. Novel microorganisms and a novel process for producing antibiotics

Also Published As

Publication number Publication date
AU7692594A (en) 1995-03-22
WO1995006649A1 (en) 1995-03-09

Similar Documents

Publication Publication Date Title
GB9300704D0 (en) Organic compounds
GB9318144D0 (en) Organic compounds
GB9306452D0 (en) Organic compounds
GB9306186D0 (en) Organic compounds
GB9303286D0 (en) Organic compounds
GB9304927D0 (en) Organic compounds
GB9301690D0 (en) Organic compounds
GB9301691D0 (en) Organic compounds
GB9301692D0 (en) Organic compounds
GB9301693D0 (en) Organic compounds
GB9301697D0 (en) Organic compounds
GB9301698D0 (en) Organic compounds
GB9302604D0 (en) Organic compounds
GB9302605D0 (en) Organic compounds
GB9302608D0 (en) Organic compounds
GB9302609D0 (en) Organic compounds
GB9302614D0 (en) Organic compounds
GB9302618D0 (en) Organic compounds
GB9302633D0 (en) Organic compounds
GB9302794D0 (en) Organic compounds
GB9302795D0 (en) Organic compounds
GB9302796D0 (en) Organic compounds
GB9302805D0 (en) Organic compounds
GB9302806D0 (en) Organic compounds
GB9302807D0 (en) Organic compounds